Molecular basis of macrolide, triamilide, and lincosamide resistance in Pasteurella multocida from bovine respiratory

Kristina Kadlec1, Geovana Brenner Michael, Michael T Sweeney

  • 1Institute of Farm Animal Genetics, Friedrich-Loeffler-Institut (FLI), Höltystr. 10, 31535 Neustadt-Mariensee, Germany.

Insights

Researchers identified three novel genes, erm(42), msr(E), and mph(E), responsible for macrolide-triamilide resistance in Pasteurella multocida. These genes confer resistance when transferred to susceptible bacteria.

Area of Science:

  • Veterinary Microbiology
  • Molecular Biology
  • Antimicrobial Resistance

Background:

  • The emergence of antibiotic resistance in bacterial pathogens poses a significant threat to animal and human health.
  • Pasteurella multocida is an important veterinary pathogen, and understanding its resistance mechanisms is crucial for effective treatment.
  • The specific mechanisms underlying macrolide-triamilide resistance in P. multocida remained largely uncharacterized.

Purpose of the Study:

  • To elucidate the genetic basis of macrolide-triamilide resistance in a multiresistant bovine isolate of Pasteurella multocida.
  • To identify and characterize novel resistance genes conferring macrolide and macrolide-triamilide resistance.

Main Methods:

  • Whole-genome sequencing of a multiresistant P. multocida isolate.
  • Identification and PCR amplification of putative resistance genes: erm(42), msr(E), and mph(E).
  • Cloning of identified genes into plasmid vectors and transformation into susceptible E. coli and P. multocida strains to assess conferred resistance.

Main Results:

  • Whole-genome sequencing revealed three novel resistance genes: erm(42) (rRNA methylase), msr(E) (macrolide transporter), and mph(E) (macrolide phosphotransferase).
  • The erm(42) gene conferred macrolide-lincosamide resistance.
  • The msr(E)-mph(E) gene combination conferred macrolide-triamilide resistance.

Conclusions:

  • Three novel genes, erm(42), msr(E), and mph(E), have been identified as key determinants of macrolide and macrolide-triamilide resistance in Pasteurella multocida.
  • These findings provide critical insights into the molecular mechanisms of resistance in this important veterinary pathogen.
  • The characterized resistance genes can be utilized for developing diagnostic tools and strategies to combat antimicrobial resistance in P. multocida infections.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...